§866.5760. Tryptase test system.
21 C.F.R. § 866.5760
Identification. A tryptase test system is a device that aids in the diagnosis of systemic mastocytosis. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of patients with a suspicion of systemic mastocytosis in conjunction with other clinical and laboratory findings.
Classification. Class II (special controls). The special control is FDA's guideline entitled “Class II Special Controls Guideline: Tryptase Test System as an Aid in the Diagnosis of Systemic Mastocytosis.” For availability of the document, see § 866.1(e).
Notes, amendments, and revision history
Amendments
[79 FR 56010, Sept. 18, 2014]
Authority
Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 360 l, 371.
Source
Source: 47 FR 50823, Nov. 9, 1982, unless otherwise noted.
Amendments
[79 FR 56010, Sept. 18, 2014]